Article
The AT1A receptor "gain-of-function" mutant N111S/delta329 is both constitutively active and hyperreactive to angiotensin II.
American journal of physiology. Endocrinology and metabolism - 1 May 2006
Billet Sandrine, Bardin Sabine, Tacine Rachida, Clauser Eric, Conchon Sophie
Abstract excerpt
The renin-angiotensin-aldosterone system (RAAS) is central to cardiovascular and renal physiology. However, there is no animal model in which the activation of the RAAS only reflects the activation of the angiotensin II (ANG II) AT1 receptor. As a first step to developing such a model, we characterized a gain-of-function mutant of the mouse AT1A receptor. This mutant carries two mutations: N111S predicted to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
